Scientific and Clinical Advisory Council

Scientific and Clinical Advisory Council

SafeMinds Scientific & Clinical Advisory Council is comprised of clinicians, health professionals, and scientists from a variety of disciplines, including, among others, specialists and experts in autism, environment, toxicology, pediatrics, neuroscience, pharmacology, and psychology.

José G. Dórea, Ph.D.
Professor of Nutritional Sciences, University of Brasília
A graduate of the University of Pernambuco with advanced degrees from the University of Massachusetts (MSc and PhD), Dr. Dorea has worked at Iowa State University (USA), University of Hawaii (USA), and University of Campinas (Brazil). He has authored numerous book chapters, and has published on infant nutrition and the environmental impact of toxic (natural and man made) substances on the growth and development of children. Dr. Dorea is on the editorial board of peer-reviewed scientific journals, and has authored and co-authored more than 180 papers in journals of public health, medical and environmental sciences, toxicology, and pharmacology.

Cindy Schneider, MD
Medical Director, Center for Autism Research and Education
Dr. Schneider is the Medical Director of CARE, the Center for Autism Research and Education. Her integrative medical practice is exclusively dedicated to individuals with autism and related neurological and immune disorders. Dr. Schneider’s areas of special interest include treatment of the immune, gastrointestinal, and metabolic aspects of autism and the identification of environmental toxins contributing to the autism epidemic. She has designed and implemented multiple research studies, and collaborated with researchers worldwide. Dr. Schneider’s priorities in both her medical practice and her research include the identification of the causes of autism, the formulation of effective treatment protocols, and the prevention of autism in future generations.

Dr. Schneider has served as a member of the Defeat Autism Now! think tank since 1997, and serves on the Clinician Advisory Committee at the Autism Research Institute. She was the founding president and medical director of two nonprofit organizations for autism research, and is a medical advisor for SafeMinds. Dr. Schneider has published extensively in the areas of genetic vulnerability to environmental toxins, and innovative treatments for the gastrointestinal and immune complications of autism.

As the mother of two children with autism and a leading authority in the field, Dr. Schneider closely tracks developments in autism research, and provides both a medical and personal assessment of current and promising treatment options.

Robert Sears, M.D.
Robert W. Sears, MD, FAAP, is a board-certified pediatrician in a full-time private practice in Dana Point, Calif. He received his medical degree from Georgetown University, and did his pediatric residency training at Childrens Hospital Los Angeles. “Dr. Bob,” as he likes to be called by his little patients, provides a unique blend of mainstream and integrative medical care. He is a co-author in the Sears Parenting Library, including The Baby Book and The Portable Pediatrician, and is the author of The Vaccine Book, The Autism Book, and HappyBaby: The Organic Guide to Baby’s First 24 Months. Dr. Bob has appeared on Dr. Oz, The Doctors, CNN, CBS Early Show, Fox Morning News, and Dr. Phil discussg parenting advice and pediatric health issues. He is a frequent speaker at parenting conferences, and serves on the medical advisory board for various organizations, including Talk About Curing Autism, Autism Care and Treatment Today, HappyBaby Organic Baby Food, and Kaplan University Department of Health Sciences. Dr. Bob is a contributor to AskDrSears.com, and regularly answers questions on his Mothering.com Ask the Experts forum.

July 19, 2021

Diagnosticians Urged to Support a More Positive Autism Diagnosis Story

Changing to Strength-Based Approach Could be Key for Better Diagnostic Experience  A recent editorial featured in the journal Autism has given diagnosticians a lot to think about. In response to the intense pain and distress parents often feel after their child is diagnosed with autism, the editorial’s authors are encouraging clinicians to change the way […]

July 19, 2021

Adults with Autism at Higher Risk for Problematic Internet Use & Gaming Disorder

Impulse Control and Response Inhibition Deficits Can Lead to Internet & Gaming Addictions The majority of the 21 research articles included in a new systematic literature review have found positive associations between problematic internet use (PIU) and gaming disorder (GD) for adults with autism. Immediately into this research, the review’s authors needed to determine abnormal […]

July 12, 2021

Presentation of Suicidal Thoughts and Behaviors in Adults with Autism

Life Transitions and Interpersonal Conflicts Common Antecedents for Suicidal Ideation  An exploratory study out of Canada is the first to examine clinical presentations of suicidal thoughts and behaviors (STB) in adults with autism spectrum disorder (ASD). In order to conduct this study, a research team performed a retrospective chart review of visits to a psychiatric […]

July 12, 2021

Lead Lingers in London After 22 Years of Leaded Fuel Ban

Up to 40% of Lead in Airborne Particles Come from Dirty Gasoline Legacy  When London banned leaded gasoline in 1999, the city’s air quality improved dramatically. London currently meets the United Kingdom’s air quality standards. However, according to new research, airborne particles found in the city are still heavily lead-enriched. In a recent study, published […]

July 12, 2021

Antidepressants Deemed Safe During Pregnancy for Mother and Baby

Although Maternal Psychiatric Conditions Increase the Risk for ASD  According to new research published in the journal Biological Psychiatry, the use of selective serotonin reuptake inhibitor (SSRI) medications during pregnancy is not associated with a higher risk of autism spectrum disorder (ASD) or developmental delays (DD) in offspring. SSRIs are the most commonly prescribed antidepressants […]

July 06, 2021

Working Group Tasked with Studying Drug Development for Treating Autism

Researchers Focused on Advances, Challenges, Barriers, and Future Directions Concerned with a lack of progress in pharmacological interventions for autism’s core deficits, the International Society for CNS Clinical Trials and Methodology (ISCTM) along with the European College of Neuropsychopharmacology (ECNP) created an autism spectrum disorder (ASD) working group to review and identify challenges encountered for […]

Show Buttons
Hide Buttons